Alfred Lim, PhD

Director of Lab Research at Etcembly Ltd.

Speaker

Alfred is Director of Lab Research at Etcembly, where he leads the development of new TCR drug candidates from discovery through to preclinical characterization and translational development. He was previously Head of Discovery at Theolytics and was responsible for candidate optimisation and lead nomination across the different pipeline programs. Alfred trained in immunology at the MRC Laboratory of Molecular Biology, Cambridge and holds a PhD in Molecular Immunology from the University of Cambridge.